Hemophilia Market Evolution: Innovative Therapies Driving Future Growth
The hemophilia treatment market is entering a pivotal decade, shaped by novel non-factor drugs, gene therapy breakthroughs, and a steadily expanding diagnosed patient base. Within the broader hemophilia market, the hemophilia A segment commands the largest share, reflecting both its higher global prevalence and the intensity of R&D activity aimed at correcting factor VIII deficiency....
0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior